Who
Jennifer Scott Perry
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Bicycle Therapeutics.
In numbers
- Trades disclosed
- 19
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $33K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 Apr 2026
- Last trade
- 5 Oct 2026
- Last filed
- 7 Oct 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 7 Oct 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $10730 at $3.57 | filing |
| 5 Oct 2026filed 7 Oct 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,232326 at $3.78 | filing |
| 5 Oct 2026filed 6 Oct 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $28580 at $3.56 | filing |
| 5 Oct 2026filed 6 Oct 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,232326 at $3.78 | filing |
| 2 Oct 2026filed 6 Oct 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,7961,094 at $3.47 | filing |
| 15 Jul 2026filed 17 Jul 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $18543 at $4.31 | filing |
| 6 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,445333 at $4.34 | filing |
| 6 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $18543 at $4.31 | filing |
| 6 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,445333 at $4.34 | filing |
| 2 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $4,4241,036 at $4.27 | filing |
| 2 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $4,4241,036 at $4.27 | filing |
| 6 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $18737 at $5.05 | filing |
| 6 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,678333 at $5.04 | filing |
| 6 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $18737 at $5.05 | filing |
| 6 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,678333 at $5.04 | filing |
| 2 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $5,0971,038 at $4.91 | filing |
| 2 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $5,0971,038 at $4.91 | filing |
News
Pyxis Oncology (NASDAQ:PYXS) and Bicycle Therapeutics (NASDAQ:BCYC) Head to Head ReviewBCYC · dailypolitical.com · 26 Oct 2026
0 headlines in the last 90 days name Jennifer Scott Perry; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.